Valion Bio (VBIO) Inventory Average (2022 - 2026)
Valion Bio (VBIO) posted quarterly Inventory Average of $596500.0 for Q3 2025, down 20.31% year-over-year from $748500.0 in Q3 2024, and up 28.69% quarter-over-quarter from $463500.0 in Q2 2025.
Valion Bio (VBIO) Inventory Average (2022 - 2026) Analysis & Trends
Valion Bio's Inventory Average history runs 4 years deep, the most recent figure standing at $596500.0 for Q3 2025.
- In Q3 2025, Inventory Average fell 20.31% year-over-year to $596500.0; the TTM figure through Sep 2025 stood at $596500.0 (down 20.31% YoY), while the FY2024 annual figure was $537500.0, down 33.6% from the prior year.
- Inventory Average for Q3 2025 stood at $596500.0, up from $463500.0 in the prior quarter.
- The five-year high for Inventory Average was $965500.0 in Q2 2023, with the low at $312500.0 in Q1 2025.
- The 4-year median for Inventory Average is $779000.0 (2024), against an average of $704300.0.
- The sharpest annual moves came in 2023 and 2025: Inventory Average soared 106.16% in 2023, then plunged 59.88% in 2025.
- Valion Bio's Inventory Average stood at $812000.0 in 2022, then rose by 3.69% to $842000.0 in 2023, then slumped by 37.65% to $525000.0 in 2024, then climbed by 13.62% to $596500.0 in 2025.
- Business Quant data shows VBIO's Inventory Average at $596500.0 in Q3 2025, $463500.0 in Q2 2025, and $312500.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | 470,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 470,000.00 |
| Dec 31, 2025 | 381,000.00 |
| Sep 30, 2025 | 596,500.00 |
| Jun 30, 2025 | 463,500.00 |
| Mar 31, 2025 | 312,500.00 |
| Dec 31, 2024 | 525,000.00 |
| Sep 30, 2024 | 748,500.00 |
| Jun 30, 2024 | 784,000.00 |
| Mar 31, 2024 | 779,000.00 |
| Dec 31, 2023 | 842,000.00 |
| Sep 30, 2023 | 958,000.00 |
| Jun 30, 2023 | 965,500.00 |
| Mar 31, 2023 | 903,000.00 |
| Dec 31, 2022 | 812,000.00 |
| Sep 30, 2022 | 797,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 438,000.00 |